EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high‐risk populations: A systematic review and meta‐analysis of randomized controlled trials

Hao Xuan Kan, Yang Cao iD, Ye Ma, Yue Lun Zhang, Jing Wang, Ji Li, Jing Nan Li

Journal of Digestive Diseases · 2024-01 · 25 (1) · 14-26

DOI: 10.1111/1751-2980.13247 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Digestive Diseases, online erschienen am 11.02.2024. Verfasst von Hao Xuan Kan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Key Laboratory of Gut Microbiota Translational Medicine Research, Chinese Academy of Medical Sciences, Peking Union M…. Hauptthemen laut MEDLINE: Probiotics, Colorectal Neoplasms, Synbiotics, Prebiotics. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 13th Five-Year Plan for the National Key R&D Program of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Colorectal cancer (CRC) is highly prevalent worldwide and is a leading cause of cancer‐related death. Probiotics, prebiotics, and synbiotics have recently attracted attention as preventive measures against colorectal neoplasms. We aimed to analyze the findings of randomized controlled trials (RCTs) on the effects of probiotics, prebiotics, and synbiotics in patients at a high risk of CRC, outlining the challenges and future prospects of using probiotics to prevent colorectal tumors and providing evidence for clinical physicians in particular.

Methods

PubMed, EMBASE, and the Cochrane Library databases were searched for relevant studies published up to January 7, 2022. RCTs conducted on populations with a high risk of CRC who received probiotics, prebiotics or synbiotics in comparison with placebo, candidate agent or no treatment were included. The primary outcome was the incidence or recurrence of any colorectal neoplasms. Additional outcomes included their effects on the diversity of gut microbiota and relevant inflammatory biomarkers. Safety outcomes were also analyzed. Two authors independently screened and selected studies based on pre‐specified eligible criteria, performed data extraction and risk‐of‐bias assessment independently.

Results

Nine RCTs were included in the systematic review and meta‐analysis. Probiotic supplementation significantly reduced adenoma incidence, but no significant benefit was observed in CRC incidence. Additionally, probiotics modulated gut microbiota and inflammatory biomarkers.

Conclusion

Probiotics may have beneficial effects in the prevention of CRC. More RCTs with larger sample sizes are warranted to further confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsColorectal NeoplasmsSynbioticsPrebioticsRandomized Controlled Trials as TopicHumansPrecancerous ConditionsGastrointestinal MicrobiomeTreatment Outcome

Stichwörter der Autor:innen

colorectal adenomacolorectal neoplasmsprebioticsprobioticssynbiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Gastroenterology, Key Laboratory of Gut Microbiota Translational Medicine Research, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
  • Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Yang Cao

Förderung

  • National Natural Science Foundation of China
  • 13th Five-Year Plan for the National Key R&D Program of China
  • CAMS Innovation Fund for Medical Sciences
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Kan, H. X., Cao, Y., Ma, Y., Zhang, Y. L., Wang, J., Li, J., & Li, J. N. (2024). Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high‐risk populations: A systematic review and meta‐analysis of randomized controlled trials. Journal of Digestive Diseases, 25(1), 14-26. https://doi.org/10.1111/1751-2980.13247

Vancouver

Kan HX, Cao Y, Ma Y, Zhang YL, Wang J, Li J, et al. Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high‐risk populations: A systematic review and meta‐analysis of randomized controlled trials. Journal of Digestive Diseases. 2024;25(1):14-26. doi:10.1111/1751-2980.13247

BibTeX
@article{Kan2024,
  author = {Kan, Hao Xuan and Cao, Yang and Ma, Ye and Zhang, Yue Lun and Wang, Jing and Li, Ji and Li, Jing Nan},
  title = {Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high‐risk populations: A systematic review and meta‐analysis of randomized controlled trials},
  journal = {Journal of Digestive Diseases},
  year = {2024},
  volume = {25},
  number = {1},
  pages = {14--26},
  doi = {10.1111/1751-2980.13247}
}
Kostenlos starten →